Expert Perspectives and Preferences in the Management of Hypertension in Indian Settings: A Nationwide Survey

Objective: To assess clinicians’ perspectives and preferences in hypertension management, with a focus on telmisartan-based therapies in Indian settings. Methodology: The cross-sectional study was conducted among 973 clinicians across India using a 23-item structured questionnaire, which collected information on treatment approaches, the use of fixed-dose combinations (FDCs), and treatment preferences. Additionally, an extended analysis comprising 15 supplementary questions was conducted with a subset of clinicians (n = 93) to further explore clinical practices in specific scenarios. The data were analyzed using descriptive statistics and presented as frequencies and percentages. Results: A large proportion of clinicians (76.67%) preferred FDCs when two or more drugs are required for hypertension management. Telmisartan was the most commonly preferred angiotensin receptor blocker (ARB), as reported by the majority (96.92%) of clinicians, with approximately 52% reporting its frequent use in combination with calcium channel blockers (CCBs). Among these, amlodipine is the most commonly preferred agent in young patients with uncontrolled hypertension, as reported by 67% of participants. Nearly half (50.15%) of respondents reported that chlorthalidone is the preferred diuretic in combination with telmisartan. About 57% of participants reported that metoprolol is the most commonly used beta-blocker in patients with hypertension and coronary artery disease. Telmisartan + CCB + beta-blocker is the most commonly preferred triple-drug combination, as indicated by 49% of participants, and 64% reported preferring this combination, particularly in young patients with uncontrolled hypertension. Conclusion: The survey findings highlight a strong preference for telmisartan-based therapies and FDCs among Indian clinicians, reflecting current clinical practices in hypertension management. The widespread use of ARBs, particularly in younger patients, underscores their perceived efficacy and tolerability.